Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Our Products
MouseAtlas
iPSC Cell Lines
Knockout Cell Lines
Tumor Cell Lines
Adeno-associated Virus (AAV) Standard Capsid
Featured Catalog
Humanized Mouse Models
HUGO-GT™
HUGO-Ab™
Humanized Target Gene Models
Humanized Immune System Mouse Models
Tool Mice
Cre Mouse Lines
Disease Models
Autoimmune Disease Models
Ophthalmic Disease Models
Immunodeficient Mouse Models
Metabolic Disease Models
Neurological Disease Models
Oncology & Immuno-oncology Models
Services
Model Generation Techniques
Turboknockoutᵀᴹ Gene Targeting
Cre-ESCs Gene Editing
Targeted Gene Editing
Genetically Engineered Animals
Knockin Mice
Knockin Rats
Knockout Mice
Knockout Rats
Transgenic Mice
Transgenic Rats
Transgenic Model Generation
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Adenovirus Packaging
Lentivirus Packaging
Custom Cell Line Services
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Overexpression Cell Lines
Point Mutation Cell Lines
Breeding & Supporting Services
BAC Modification
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
Drug Discovery and Development
Antibody Discovery Platform
HUGO-Ab™
HUGO-Mab™
HUGO-Light™
HUGO-Nano™
HUGO-Ab-eKO™
Therapeutic Area
Neurology
Alzheimer's Disease (AD)
Parkinson's Disease (PD)
Huntington's Disease (HD)
Blood Brain Barrier (BBB)
Neuropathic Pain
Metabolic & Cardiovascular
Obesity
Ophthalmology
Glaucoma
Age-Related Macular Degeneration (AMD)
Oncology
PBMC Humanized Mouse Model
Human Immune System (HIS) Mouse Model
Immunology & Inflammation
Asthma
Innovative Drug R&D
Therapeutic Antibody Drugs
Monoclonal Antibodies (mAb)
Bispecific Antibodies (BsAb)
ADC/AOC
AI-Powered AAV Discovery
Cell Immunotherapy
Gene Therapy
Oligonucleotide Therapy
Fully Human Antibody Library
Neurology Antibodies
Metabolic & Cardiovascular Antibodies
Ophthalmology Antibodies
Oncology Antibodies
Immunology & Inflammation Antibodies
Resources
News
Blogs & Insight
Promotion
Events & Webinars
Databases
AbSeek
Rare Disease Data Center
Cell iGeneEditor™ System
Citations
Resource Vault
OriCell
About Us
Animal Health & Welfare
Corporate Overview
Facility Overview
Our Team
Our Partners
Careers
Health Reports
Contact Us
Login
HomeMouseAtlas
C57BL/6JCya-Ythdc1em1/Cya
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
+
-
Organization
Job Role
Country
Catalog Type
Product Name
Main Area of Research
How did you hear about us?
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.

C57BL/6JCya-Ythdc1em1/Cya

Common Name
Ythdc1-KO
Product ID
S-KO-06435
Backgroud
C57BL/6JCya
Strain ID
KOCMP-231386-Ythdc1-B6J-VB
Status
Research and Development
When using this mouse strain in a publication, please cite “Ythdc1-KO Mouse (Catalog S-KO-06435) were purchased from Cyagen.”
KO Models
Product Type
Age
Genotype
Sex
Quantity
The standard delivery applies for a guaranteed minimum of three heterozygous carriers. Breeding services for homozygous carriers and/or specified sex are available.
+
KO Models
Basic Information
Strain Name
Ythdc1-KO
Strain ID
KOCMP-231386-Ythdc1-B6J-VB
Gene Name
Ythdc1
Product ID
S-KO-06435
Gene Alias
mKIAA1966, A730098D12Rik
Background
C57BL/6JCya
Gene Full Name
YTH domain containing 1
Modification
Conventional knockout
NCBI ID
231386 (Mouse)
Phenotype
MGI:2443713
Chromosome
Chr 5 (Mouse)
Application
--
Datasheet
Click here to download >>
More
Rare Disease Data Center >>
Strain Description
Ensembl Transcript ID
ENSMUST00000038384
NCBI Transcript ID
NM_177680
Target Region
Exon 5~7
Size of Effective Region
~2.5 kb
Overview of Gene Research
YTHDC1, short for YTH domain containing 1, is a nuclear N6-methyladenosine (m6A) reader protein. m6A is a prevalent internal modification of eukaryotic mRNA, and YTHDC1 is involved in multiple RNA-related metabolic processes such as mRNA splicing, export, and stability regulation [1,4]. These functions are crucial for various biological processes like cell proliferation, differentiation, and organismal development, and are also associated with disease-related pathways [1-10]. Genetic models, especially knockout (KO) mouse models, have been instrumental in uncovering its functions.

In mouse models, genetic deletion of Ythdc1 markedly blocks acute myeloid leukemia (AML) development and maintenance, as well as self-renewal of leukemia stem cells (LSCs), indicating its oncogenic role in AML [3]. In lung cancer, YTHDC1 knockdown promoted tumor progression and upregulated FSP1 protein level, leading to ferroptosis resistance, suggesting it as a tumor progression suppressor [2]. In muscle stem cells, absence of Ythdc1 led to an inability to exit quiescence, highlighting its importance in muscle stem cell proliferation [5]. Also, deletion of Ythdc1 in mouse embryonic stem (ES) cells initiated cellular reprogramming to a 2C-like state, revealing its role in maintaining ES cell identity [6].

In conclusion, YTHDC1 plays essential roles in multiple biological processes such as cell proliferation, tumor suppression, and stem cell maintenance. The KO/CKO mouse models have significantly contributed to understanding its functions in diseases like AML, lung cancer, and potentially others. These findings enhance our knowledge of YTHDC1-related biological mechanisms and may provide insights for disease treatment strategies [2,3,5,6].

References:
1. Xiao, Wen, Adhikari, Samir, Dahal, Ujwal, Zhao, Yong-Liang, Yang, Yun-Gui. 2016. Nuclear m(6)A Reader YTHDC1 Regulates mRNA Splicing. In Molecular cell, 61, 507-519. doi:10.1016/j.molcel.2016.01.012. https://pubmed.ncbi.nlm.nih.gov/26876937/
2. Yuan, Shuai, Xi, Shu, Weng, Hong, Zeng, Xian-Tao, Hu, Hailiang. 2023. YTHDC1 as a tumor progression suppressor through modulating FSP1-dependent ferroptosis suppression in lung cancer. In Cell death and differentiation, 30, 2477-2490. doi:10.1038/s41418-023-01234-w. https://pubmed.ncbi.nlm.nih.gov/37903990/
3. Sheng, Yue, Wei, Jiangbo, Yu, Fang, He, Chuan, Qian, Zhijian. . A critical role of nuclear m6A reader YTHDC1 in leukemogenesis by regulating MCM complex-mediated DNA replication. In Blood, 138, 2838-2852. doi:10.1182/blood.2021011707. https://pubmed.ncbi.nlm.nih.gov/34255814/
4. Roundtree, Ian A, Luo, Guan-Zheng, Zhang, Zijie, Shen, Bin, He, Chuan. 2017. YTHDC1 mediates nuclear export of N6-methyladenosine methylated mRNAs. In eLife, 6, . doi:10.7554/eLife.31311. https://pubmed.ncbi.nlm.nih.gov/28984244/
5. Liu, Jin, Zuo, Hongna, Wang, Ziliu, Wang, Hu, Ju, Zhenyu. 2023. The m6A reader YTHDC1 regulates muscle stem cell proliferation via PI4K-Akt-mTOR signalling. In Cell proliferation, 56, e13410. doi:10.1111/cpr.13410. https://pubmed.ncbi.nlm.nih.gov/36722312/
6. Liu, Jiadong, Gao, Mingwei, He, Jiangping, Bao, Xichen, Chen, Jiekai. 2021. The RNA m6A reader YTHDC1 silences retrotransposons and guards ES cell identity. In Nature, 591, 322-326. doi:10.1038/s41586-021-03313-9. https://pubmed.ncbi.nlm.nih.gov/33658714/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Inquiry Details
Main Area of Research
Service(s) of Interest
Gene of Interest
Project Details
How did you hear about us?
Contact Information
Full Name
Email
Phone Number
+
-
Organization
Job Role
Country
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our  Privacy Policy  for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0336
Email:
inquiry@cyagen.com
Services
HUGO-GT™HUGO-Ab™iPSC Cell LinesAdeno-associated Virus (AAV) Standard Capsid
Drug R&D
NeurologyMetabolicOphthalmologyOncology
About Us
Animal Health & WelfareCorporate OverviewOur TeamHealth Reports
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Global Antibody Drug Industry Development BlueBook (Frost & Sullivan)
Key Insights
The industry is undergoing a rapid transformation driven by next-generation modalities, globalized markets, and upstream technological innovations.
  • Market Structural Shift: Monoclonal antibodies drive steady growth, but ADCs and bispecifics are rapidly accelerating, reshaping the market with higher-value innovations.
  • Chinese Market Globalization: China is actively expanding globally, evidenced by a surge in high-value cross-border license-out deals.
  • Technology-Driven Efficiency: Advanced discovery engines—exemplified by Cyagen's HUGO-Ab platform and AI algorithms—are streamlining candidate screening, optimizing molecular design, and localizing the upstream supply chain.
  • Oncology-Focused Innovation: R&D pipelines remain heavily concentrated on high-incidence malignancies like non-small cell lung cancer, utilizing complex modalities to combat clinical resistance.
Now Available for Download
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest
Main Area of Research